S&S Healthcare Holding Ltd.(TW:4198)
NT$48.00+2.30 (+5.03%)
TW:4198
S&S Healthcare Holding Ltd. financials statements
NT$48.00
At close:+2.30 (+5.03%)
S&S Healthcare Holding Ltd. (4198) Ratios
S&S Healthcare Holding Ltd. Ratios
TW:4198's free cash flow for Q2 2026 was NT$-6.02M. For the 2026 fiscal year, TW:4198's free cash flow was decreased by NT$-43.00K and operating cash flow was NT$-5.98M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.93 | 3.57 | 3.14 | 2.23 | 2.69 |
| Quick Ratio | 2.43 | 3.03 | 2.55 | 1.42 | 2.02 |
| Cash Ratio | 1.26 | 1.74 | 1.56 | 0.79 | 1.51 |
| Solvency Ratio | -0.28 | -0.13 | 0.62 | -0.10 | -0.37 |
| Operating Cash Flow Ratio | -0.30 | -0.60 | -0.53 | -0.51 | -0.87 |
| Short-Term Operating Cash Flow Coverage | -2.23 | -2.78 | -12.42 | -11.14 | -46.64 |
| Net Current Asset Value | NT$ 162.49M | NT$ 191.74M | NT$ 190.68M | NT$ 636.00K | NT$ 17.38M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.12 | 0.14 | 0.35 | 0.42 |
| Debt-to-Equity Ratio | 0.13 | 0.20 | 0.29 | 1.36 | 2.26 |
| Debt-to-Capital Ratio | 0.11 | 0.17 | 0.23 | 0.58 | 0.69 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.09 | 0.19 | 0.56 | 0.68 |
| Financial Leverage Ratio | 1.66 | 1.66 | 2.04 | 3.93 | 5.35 |
| Debt Service Coverage Ratio | -2.04 | -0.95 | 12.48 | -3.63 | -22.06 |
| Interest Coverage Ratio | -45.26 | -31.56 | -17.73 | -22.96 | -54.32 |
| Debt to Market Cap | 0.02 | 0.06 | 0.13 | 0.38 | 0.26 |
| Interest Debt Per Share | 1.22 | 2.30 | 4.05 | 10.51 | 8.59 |
| Net Debt to EBITDA | 3.13 | 5.49 | -0.83 | -2.13 | -0.03 |
| Profitability Margins | |||||
| Gross Profit Margin | 28.82% | 31.22% | 12.96% | 15.09% | -6.48% |
| EBIT Margin | -22.80% | -18.38% | 39.29% | -26.73% | -76.55% |
| EBITDA Margin | -13.23% | -7.32% | 48.64% | -13.21% | -58.55% |
| Operating Profit Margin | -22.80% | -28.48% | -33.78% | -21.38% | -77.02% |
| Pretax Profit Margin | -23.73% | -19.28% | 37.39% | -27.66% | -77.97% |
| Net Profit Margin | -23.16% | -17.18% | 37.66% | -26.29% | -77.97% |
| Continuous Operations Profit Margin | -23.48% | -20.22% | 37.40% | -27.18% | -77.97% |
| Net Income Per EBT | 97.61% | 89.10% | 100.73% | 95.05% | 100.00% |
| EBT Per EBIT | 104.05% | 67.72% | -110.70% | 129.36% | 101.23% |
| Return on Assets (ROA) | -12.54% | -9.51% | 16.89% | -12.59% | -32.43% |
| Return on Equity (ROE) | -20.88% | -15.82% | 34.45% | -49.45% | -173.47% |
| Return on Capital Employed (ROCE) | -16.21% | -19.68% | -19.13% | -13.97% | -44.20% |
| Return on Invested Capital (ROIC) | -15.10% | -18.45% | -18.68% | -13.39% | -43.18% |
| Return on Tangible Assets | -13.44% | -10.30% | 18.23% | -13.90% | -32.57% |
| Earnings Yield | -5.37% | -5.35% | 18.38% | -14.24% | -20.89% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.61 | 4.56 | 3.39 | 4.52 | 7.27 |
| Payables Turnover | 11.19 | 13.31 | 16.81 | 4.91 | 5.25 |
| Inventory Turnover | 3.26 | 3.55 | 3.19 | 1.88 | 2.43 |
| Fixed Asset Turnover | 7.06 | 8.62 | 2.20 | 1.93 | 2.09 |
| Asset Turnover | 0.54 | 0.55 | 0.45 | 0.48 | 0.42 |
| Working Capital Turnover Ratio | 1.03 | 0.97 | 1.23 | 1.64 | 1.01 |
| Cash Conversion Cycle | 180.44 | 155.61 | 200.08 | 200.60 | 130.80 |
| Days of Sales Outstanding | 101.07 | 80.10 | 107.54 | 80.73 | 50.24 |
| Days of Inventory Outstanding | 112.00 | 102.93 | 114.25 | 194.17 | 150.02 |
| Days of Payables Outstanding | 32.62 | 27.42 | 21.71 | 74.31 | 69.46 |
| Operating Cycle | 213.07 | 183.03 | 221.79 | 274.91 | 200.26 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.11 | -2.16 | -2.95 | -4.11 | -4.82 |
| Free Cash Flow Per Share | -1.21 | -2.95 | -4.30 | -8.02 | -5.49 |
| Dividend Paid and CapEx Coverage Ratio | -10.83 | -2.73 | -2.19 | -1.05 | -7.17 |
| Capital Expenditure Coverage Ratio | -10.83 | -2.73 | -2.19 | -1.05 | -7.17 |
| Operating Cash Flow Coverage Ratio | -0.94 | -0.98 | -0.77 | -0.40 | -0.57 |
| Operating Cash Flow to Sales Ratio | -0.13 | -0.22 | -0.25 | -0.29 | -0.58 |
| Free Cash Flow Yield | -3.31% | -9.22% | -17.61% | -30.25% | -17.60% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -18.62 | -18.71 | 5.45 | -7.03 | -4.79 |
| Price-to-Sales (P/S) Ratio | 4.31 | 3.21 | 2.05 | 1.85 | 3.73 |
| Price-to-Book (P/B) Ratio | 3.88 | 2.96 | 1.87 | 3.47 | 8.30 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -30.22 | -10.85 | -5.68 | -3.31 | -5.68 |
| Price-to-Operating Cash Flow Ratio | -33.01 | -14.83 | -8.28 | -6.44 | -6.48 |
| Price-to-Earnings Growth (PEG) Ratio | -1.27 | 0.14 | -0.02 | 0.17 | 0.16 |
| Enterprise Value Multiple | -29.44 | -38.34 | 3.38 | -16.10 | -6.40 |
| Enterprise Value | 795.50M | 674.76M | 452.81M | 541.24M | 458.85M |
| EV to EBITDA | -29.44 | -38.34 | 3.38 | -16.10 | -6.40 |
| EV to Sales | 3.90 | 2.81 | 1.65 | 2.13 | 3.75 |
| EV to Free Cash Flow | -27.32 | -9.49 | -4.56 | -3.81 | -5.71 |
| EV to Operating Cash Flow | -29.84 | -12.97 | -6.65 | -7.42 | -6.51 |
| Tangible Book Value Per Share | 10.43 | 11.80 | 15.57 | 9.35 | 6.35 |
| Shareholders’ Equity Per Share | 9.40 | 10.82 | 13.04 | 7.63 | 3.76 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | -0.05 | -0.00 | 0.02 | 0.00 |
| Revenue Per Share | 8.47 | 9.97 | 11.93 | 14.36 | 8.36 |
| Net Income Per Share | -1.96 | -1.71 | 4.49 | -3.77 | -6.52 |
| Tax Burden | 0.98 | 0.89 | 1.01 | 0.95 | 1.00 |
| Interest Burden | 1.04 | 1.05 | 0.95 | 1.03 | 1.02 |
| Research & Development to Revenue | 0.04 | 0.04 | 0.05 | 0.08 | 0.20 |
| SG&A to Revenue | 0.52 | 0.56 | 0.41 | 0.45 | 0.59 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.56 | 1.12 | -0.66 | 1.04 | 0.74 |
Currency in TWD
